Metabolic disorders, such as diabetes and higher BMI, have been reported as risk factors for ALT abnormalities.[21,35,36] Some studies suggest body weight gain after NA treatment.[37] In the study, there were no differences in body weight before and after 1 year of NA therapy, and were not a factor affecting ALT normalization. Here, GPT is linked to metabolic disease.